Harvest Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.98M Buy
+36,770
New +$1.77M 1.12% 33
2025
Q2
$1.37M Buy
29,605
+330
+1% +$16.2K 0.88% 47
2025
Q1
$1.79M Sell
29,275
-145
-0.5% -$8.45K 1.29% 26
2024
Q4
$1.66M Sell
29,420
-835
-3% -$46.7K 1.15% 27
2024
Q3
$1.57M Buy
30,255
+1,075
+4% +$50.4K 1.07% 33
2024
Q2
$1.21M Buy
29,180
+1,387
+5% +$62.1K 0.89% 46
2024
Q1
$1.51M Buy
27,793
+5,534
+25% +$282K 1.13% 33
2023
Q4
$1.14M Buy
22,259
+798
+4% +$41.9K 0.92% 48
2023
Q3
$1.25M Buy
21,461
+364
+2% +$22.3K 1.12% 37
2023
Q2
$1.35M Sell
21,097
-30
-0.1% -$2.01K 1.16% 33
2023
Q1
$1.46M Buy
21,127
+60
+0.3% +$4.23K 1.3% 21
2022
Q4
$1.52M Buy
+21,067
New +$1.59M 1.42% 19

Other funds holding BMY

Harvest Investment Advisors's BMY Position: Q4 2025 in Review

Harvest Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 36,770 shares worth $1.98M. The stake represents 1.12% of the portfolio and ranks #33 among its holdings. This is a return to the name: Harvest Investment Advisors previously reported a position in BMY as recently as Q2 2025.

Harvest Investment Advisors first reported a position in BMY in Q4 2022 and has held it in 12 quarters since. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Harvest Investment Advisors held 36,770 shares of Bristol-Myers Squibb worth $1.98M as of Q4 2025.
  • Bristol-Myers Squibb was a new Harvest Investment Advisors position in Q4 2025.
  • Bristol-Myers Squibb made up 1.12% of Harvest Investment Advisors's portfolio in Q4 2025, its #33 holding.
  • Harvest Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 12 quarters since.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Harvest Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.